Revenue: Not disclosed for QQ1 2025; Q4 2024 revenue was 5,887,540 USD. Gross profit for QQ1 2025 is not reported; QQ4 2024 gross profit was 870,906 USD. Operating income: -34,785 USD in QQ1 2025 vs -52,880 USD in QQ4 2024, indicating a 34.2% QoQ improvement in operating losses. Net income: -43,343 USD in QQ1 2025 vs -274,007 USD in QQ4 2024, representing a QoQ improvement of approximately 84% in the absolute loss. EPS: -0.0014 in QQ1 2025, a QoQ and YoY improvement relative to prior quarters; YoY EPS change is reported as -79.71% in the provided metrics table, reflecting the unusual starting base for a micro-cap with volatile quarterly results. EBITDA: -34,785 USD in QQ1 2025; interest expense: 8,558 USD in QQ1 2025. Cash flow from operations: -23,487 USD in QQ1 2025; free cash flow: -23,487 USD. Cash at end of period: 7,211 USD. Net debt: 163,398 USD. Current ratio: 0.0525; quick ratio: 0.0525; cash ratio: 0.0331. Total assets: 11,411 USD; total current liabilities: 217,558 USD; short-term debt: 170,609 USD; total debt: 170,609 USD; retained earnings: -17,558,753 USD; stockholders’ equity: -206,147 USD. These figures underscore a highly leveraged, liquidity-constrained balance sheet with negative equity and constrained operating cash flow.